| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
24,643 |
22,585 |
$2.22M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,949 |
10,301 |
$958K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,498 |
4,413 |
$418K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,032 |
2,968 |
$300K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,871 |
5,524 |
$78K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,683 |
13,064 |
$48K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,368 |
4,161 |
$25K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
165 |
161 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
859 |
841 |
$10K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
984 |
972 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,578 |
1,546 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
96 |
95 |
$8K |
| 87400 |
|
1,364 |
873 |
$6K |
| 99215 |
Prolong outpt/office vis |
16 |
16 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
15 |
$1K |
| 99000 |
|
135 |
124 |
$788.40 |
| 87807 |
|
397 |
387 |
$330.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
135 |
132 |
$220.00 |
| 81002 |
|
247 |
237 |
$110.00 |
| 99051 |
|
3,506 |
3,302 |
$28.00 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
76 |
74 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
12 |
12 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
27 |
27 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
106 |
105 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
128 |
125 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
33 |
32 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
41 |
41 |
$0.00 |
| 90686 |
|
15 |
15 |
$0.00 |